RPL32P14

Across TCGA patient cohorts, RPL32P14 RNA expression is significantly associated with the go_rna of many other GO terms, with 4,910 significant associations in total. STAD shows the largest number of these associations.

The most reproducible RPL32P14-associated GO terms across cancer lineages are RNA methylation, Glucan metabolic process, and Long-term synaptic potentiation. Each is linked with RPL32P14 in more than 3 cancer types. Because this analysis shows association rather than direction, both RPL32P14-to-partner and partner-to-RPL32P14 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, RNA methylation grouped by RPL32P14-low versus RPL32P14-high in STAD.

RNA expression associated GO terms by consensus

Ranked by combined sampling and lineage consensus. X-score (RPL32P14→partner) and Y-score (partner→RPL32P14) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner GO term	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
STAD	RNA methylation →	+0.128	+0.034	<.001	<.001	3	3
STAD	Glucan metabolic process →	+0.107	+0.038	<.001	<.001	3	3
STAD	Long-term synaptic potentiation →	+0.051	+0.063	<.001	<.001	3	3
STAD	Positive regulation of peptide secretion →	+0.070	+0.033	<.001	<.001	3	3
STAD	Positive regulation of small molecule metabolic process →	+0.089	+0.080	<.001	<.001	3	2
ESCA	Response to rapamycin →	+0.172	+0.107	<.001	.008	2	3

Each partner links to its Q-omics profile. Showing the 6 strongest of 4,910 associations by consensus.

RNA methylation by RPL32P14 expression — STAD

Explore this box plot interactively →